Market cap
$764.3B
Price as of
2026-10-29
Latest filing
8-K
Alerts
8
Price$192.04 -6.31% 3M daily closessample
226.74192.04
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 27INS
- Oct 21INS
- Oct 13INS
- Oct 08INS
- Sep 30INS
- Sep 23INS
- Sep 18INS
- Sep 09INS
Company facts
SEC EDGAR registration- Name
- Rapport Therapeutics, Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- Smart-money score
- +12sample, -100 to +100
- Reporting currency
- USD
Who is positioning in RAPP
sample- Insiders
- 11 insider transactions over 90 days, net selling, $549.3M
- Congress
- 3 members traded over 90 days
- Institutions · 13F
- 34 funds hold $4.2B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$25.9B +16.8% y/y
Q4 2024Q3 2026
Inventory$14.9B +11.1% y/y
Q4 2024Q3 2026
Accounts receivable$11.0B +8.7% y/y
Q4 2024Q3 2026
Total debt$30.3B +17.9% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $433.8B +14.5% 3M
- Sample peer B
- $501.5B +13.8% 3M
- Sample peer C
- $522.1B +0.9% 3M
- Sample peer D
- $706.0B +4.7% 3M
- Sample peer E
- $724.3B +3.4% 3M